GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » 3-Year Dividend Growth Rate

SNN (Smith & Nephew) 3-Year Dividend Growth Rate : 1.90% (As of Jun. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Smith & Nephew 3-Year Dividend Growth Rate?

Smith & Nephew's Dividends per Share for the six months ended in Jun. 2024 was $0.46.

The historical rank and industry rank for Smith & Nephew's 3-Year Dividend Growth Rate or its related term are showing as below:

SNN' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -53.9   Med: 7.15   Max: 82.4
Current: 1.9

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Smith & Nephew was 82.40% per year. The lowest was -53.90% per year. And the median was 7.15% per year.

SNN's 3-Year Dividend Growth Rate is ranked worse than
77.25% of 189 companies
in the Medical Devices & Instruments industry
Industry Median: 11.9 vs SNN: 1.90

During the past 3 years, the average Dividends Per Share Growth Rate was 1.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 1.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Smith & Nephew's Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.94. As of today, Smith & Nephew's Dividend Yield % is 2.94%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Smith & Nephew PLC is 1.08, which seems too high.

Good Sign:

Smith & Nephew PLC stock dividend yield is close to 1-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Smith & Nephew's 3-Year Dividend Growth Rate

For the Medical Devices subindustry, Smith & Nephew's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew's 3-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's 3-Year Dividend Growth Rate falls into.



Smith & Nephew 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Smith & Nephew  (NYSE:SNN) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Smith & Nephew's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0.462/ 0.49
=0.94

During the past 13 years, the highest Dividend Payout Ratio of Smith & Nephew was 1.07. The lowest was 0.34. And the median was 0.41.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Smith & Nephew PLC is 1.08, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Smith & Nephew Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.2880002024-10-042024-10-042024-11-08Cash Dividendsemi-annuallyUSD:USD 1.000000
USD 0.4620002024-04-012024-04-022024-05-22Cash Dividendsemi-annuallyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Smith & Nephew's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.75/25.53
=2.94 %

Current Share Price is $25.53.
Smith & Nephew's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.75.

During the past 13 years, the highest Dividend Yield of Smith & Nephew was 3.54%. The lowest was 1.40%. And the median was 1.87%.

Good Sign:

Smith & Nephew PLC stock dividend yield is close to 1-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smith & Nephew 3-Year Dividend Growth Rate Related Terms>


Smith & Nephew Business Description

Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.